FoxO is required for the activation of hypertrehalosemic hormone expression in cockroaches by Castillo, Songül Süren et al.
 1 
FoxO is required for the activation of hypertrehalosemic hormone expression in 
cockroaches 
 
 
 
Songül Süren-Castillo, Marc Abrisqueta, José L. Maestro
*
 
 
Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Passeig Marítim de 
la Barceloneta 37-49. 08003 Barcelona, Spain. 
 
*
 Corresponding author. J.L. Maestro: Tel. +34 932309639; fax +34 932309555; e-
mail address joseluis.maestro@ibe.upf-csic.es. 
*REVISED Manuscript (text UNmarked)
Click here to view linked References
 2 
ABSTRACT 
 
Background: FoxO proteins are a subgroup of the Forkhead-box family of 
transcription factors, which function as the main transcriptional effectors of the 
Insulin Receptor pathway. This pathway, activated by the binding of insulin or IGFs 
(or insect insulin-like peptides), promotes the phosphorylation and inactivation of 
FoxO because of its export from the nucleus to the cytoplasm. The homolog of FoxO 
in the cockroach Blattella germanica works in a situation of nutrient shortage by 
inhibiting the endocrine induction of reproduction. 
Methods: Using Blattella germanica as a model, we studied the functions of FoxO 
using RNA interference methodologies. We analyzed the mRNA levels of 
hypertrehalosemic hormone (HTH) and genes related to lipolysis, glycogenolysis and 
gluconeogenesis and quantified triacylglycerides, glycogen and trehalose. 
Results: FoxO knockdown eliminates the starvation-induced expression of HTH in 
the corpora cardiaca. In addition, FoxO knockdown prevents the activation of the 
expression of Brummer lipase, glycogen phosphorylase and phosphoenolpyruvate 
carboxylase in the fat body of starved females. 
Conclusions: Starvation-induced activation of FoxO stimulates the transcription of 
different genes related to catabolic processes, including HTH and genes involved in 
lipolysis, glycogenolysis and gluconeogenesis. 
General significance: Our results show conservation in the action of the transcription 
factor FoxO in the activation of catabolic processes from basal insects to vertebrates. 
The results also describe a new and essentially different mode of action of 
transcription factor FoxO, which works through the activation of neuropeptide HTH 
expression, which will subsequently produce its own catabolic stimulatory function. 
 
 
 
Keywords: FoxO, insulin, catabolism, hypertrehalosemic/adipokinetic hormone, 
glucagon, Blattella germanica 
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1. Introduction 
 
Multicellular organisms have a complex system to maintain homeostasis and to 
regulate their response to changing nutrient conditions. Hormone-controlled anabolic 
and catabolic processes serve to regulate the flow of carbon and ensure adequate 
levels of circulatory sugars. One difference between insects and mammals, among 
other major distinctions, is that the primary circulating sugar in insects is trehalose, 
the non-reducing disaccharide of glucose. Insulin signaling is involved, however, in 
the regulation of circulating sugar levels in both cases [1-3]. Insulin-like peptides in 
insects are homologous to mammal insulin as well as being functionally equivalent 
[4]. Insect genomes contain multiple genes encoding insulin-like molecules: eight in 
Drosophila melanogaster [5-7], seven in the mosquito Anopheles gambiae [8], and as 
much as thirty-nine in the silkmoth Bombyx mori [9-10].  
The main insect hormones that counteract insulin signaling at metabolic levels are 
the adipokinetic/hypertrehalosemic hormones (AKH/HTH) which are the insect 
functional analogs of glucagon [11-12]. This group comprises a large family of 
peptides synthesized in the corpora cardiaca (CC), a gland placed in a retrocerebral 
position and innervated to the brain [13]. Depending on the species, the activity of 
these peptides has been described as hypertrehalosemic, hyperlipemic (adipokinetic), 
hyperprolinemic or as a mixture of these activities [14].  Thus, in cockroaches, 
peptide hormones belonging to this family have been described as hypertrehalosemic 
since their discovery [15] and were named accordingly. In the cockroach Blattella 
germanica a hypertrehalosemic hormone (HTH) has already been described and its 
function in the induction of trehalose release demonstrated [12]. 
Besides the effect of anabolic and catabolic hormones, the signaling pathways that 
regulate levels of circulatory trehalose and glucose are also affected by transcription 
factors, for example, the Forkhead-box O (FoxO). To date, four FoxO genes have 
been described in the mouse genome [16], although in most invertebrate species only 
one gene has been detected, e.g. DAF-16 in Caenorhabditis elegans [17] and dFoxO 
in D. melanogaster  [18]. FoxO is the main transcriptional effector of the Insulin 
Receptor pathway. When the pathway is active, mainly in a nutrient-dependent way, 
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FoxO is phosphorylated and retained in the cytoplasm, whereas the inactivation of the 
pathway allows dephosphorylated FoxO to enter into the nucleus and exert its 
transcriptional activity [19-20]. Kramer and co-workers [21] demonstrated that FoxO 
transcription factor is activated upon amino acid starvation in D. melanogaster and 
that this activation is required for the animals to survive under this adverse condition. 
Genome-wide evolutionary conservation of FoxO targets between the fly and the 
worm C. elegans have been reported [22]. The regulation of metabolism related genes 
via FoxO has been also described in mammals [23], which confirms a general action 
of FoxO transcription factors on metabolism regulation. In particular, the 
transcriptional activity of FoxO promotes catabolic routes and inhibits anabolic ones 
[20, 23-24]. 
In B. germanica, one cDNA coding for a FoxO homolog (BgFoxO) has recently 
been cloned, and its inhibitory role on juvenile hormone biosynthesis and vitellogenin 
production in a situation of nutrient shortage has been reported [25]. In the present 
paper, we use B. germanica as a model for analyzing the function of FoxO on the 
activation of catabolic pathways in insects. We have studied the effect of FoxO 
knockdown, using it to analyze FoxO function in the regulation of the endocrine and 
metabolic changes that occur during insect starvation.  
Two different (and in principle unrelated) systems control energy expenditure in 
insects [26]. One of them relies on the hormonal signal of the neuropeptide 
AKH/HTH which, after binding to a G protein-coupled receptor, produces an 
activation of protein kinase A (PKA) and an increase of the corresponding 
intracellular second messengers, calcium and cyclic AMP, which in turn activates 
some catabolic enzymes, among them glycogen phosphorylase (GlyP) [14, 26]. An 
analogous system functions in vertebrates, where stimulation of glucagon and β-
adrenergic receptors activates PKA and a series of energy mobilization enzymes [27]. 
The second system that controls energy expenditure in insects works via the 
regulation of Brummer lipase (Bmm) activity. This enzyme, homologous to the 
mammalian adipose triglyceride lipase (ATGL), promotes the mobilization of lipids 
from the fat body in response to food deprivation [28]. Recent studies have 
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demonstrated that in D. melanogaster, Bmm expression is activated through a direct 
binding of the transcription factor dFoxO to its promoter [29]. 
Results presented in this work indicate that FoxO activates the expression of HTH 
in the CC of starved animals. In addition, FoxO activates the expression of critical 
enzymes in lipolysis, glycogenolysis and gluconeogenesis. Together our results show 
that FoxO is a key factor in the activation of catabolism in insects, through both the 
activation of an endocrine pathway (HTH) and through the activation of enzyme 
expression. 
 
2. Material and methods 
 
2.1. Insects 
 
Specimens of B. germanica were obtained from a colony reared with dog chow 
and water, in the dark at 30 ± 1C and 60-70% relative humidity. For the study of 
gene expression levels during the first gonadotrophic cycle, virgin females were used. 
For the RNAi experiments, we induced a second gonadotrophic cycle by removing 
the ootheca at the twelfth day of its transport period. For the starvation experiments, 
animals received only water after the imaginal moult or after the induction of the 
second gonadotrophic cycle. Dissections of the different tissues were carried out on 
carbon dioxide-anesthetized specimens. After dissection, tissues were immediately 
frozen in liquid and stored at -80˚C 
 
2.2. Cloning of Bmm, GlyP, AspAT, PC and PEPCK cDNAs 
 
Degenerated primers based on conserved regions of insect brummer lipase 
(Bmm), glycogen phosphorylase (GlyP), aspartate aminotransferase (AspAT), 
pyruvate carboxylase (PC) and phosphoenol pyruvate carboxykinase (PEPCK) 
sequences were used to obtain a B. germanica homologue cDNA fragment of each of 
these genes. Primers can be found as Supplementary data, Table 1. The ampliﬁed 
fragments were subcloned into the pSTBlue-1 vector (Novagen; 70596) and 
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sequenced. In the case of PEPCK, 3’- and 5’-RACE methodologies (5΄- and 3΄-RACE 
System Version 2.0; Invitrogen) were used to complete the sequence. 
 
2.3. RNA extraction, cDNA synthesis and real-time PCR analyses 
 
The CC, fat body and muscle expression levels of the studied genes were 
analyzed using real-time PCR. cDNA was synthesized from total RNA as previously 
described [25, 30]. An amount of 0.5 mg of total RNA was used in the case of fat 
bodies, whereas in the case of muscle and CC, the total amount of RNA obtained 
from all legs and the whole gland, respectively were used. The absence of genomic 
contamination was checked using a control without reverse transcription. cDNA 
levels were quantiﬁed by using iQSYBR Green supermix (Bio-Rad) in an iQ cycler 
and iQ single colour detection system (Bio-Rad) as previously described [31]. Primer 
sequences to amplify BgFoxO and BgActin 5C (used as housekeeping gene) can be 
found in [25], whereas sequences to amplify BgHTH, BgBmm, BgGlyP, BgAspAT, 
BgPC, BgPEPCK can be found as Supplementary data, Table 1. All reactions were 
run in duplicate or triplicate. Real-time data were collected by iQ5 optical system 
software v.2.0 (BioRad). Results are given as copies of a determined mRNA per 
copies of BgActin 5C. 
 
2.4. RNA Interference 
 
Systemic RNAi in vivo in females of B. germanica was performed as previously 
described [25, 30]. A 298 bp fragment (dsFoxO) encompassing the protein C- 
terminus and part of the 3’ non-coding region, spanning position 1918 to 2215 of the 
BgFoxO cDNA, was used to generate dsRNA [25]. As a control, a heterologous 307 
bp fragment from the polyhedrin of Autographa californica nucleopolyhedrovirus 
(dsMock) was used [32]. To be conﬁdent that the treatment produced a sufficient 
BgFoxO reduction, we performed long time treatments. They consist in the injection 
of 2 μg of the dsRNA fragment into the abdomen of females in the ﬁrst day of 
ootheca transport. Twelve days later, we removed the ootheca, triggering the 
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beginning of a second gonadotrophic cycle in all respects similar to the ﬁrst one. In 
addition, using this experimental model we avoid the possible developmental 
phenotypes caused by RNAi treatment at the nymphal stages and only concentrate in 
the effects of BgFoxO RNAi treatment in the adult. After removing the ootheca, one 
group of each treatment (dsMock or dsFoxO) was maintained with food and water 
(fed group), whereas another group was kept with water but without food (starved 
group). Dissections were performed immediately after ootheca removal, so before the 
separation of fed and starved groups (0d) and 5 days later (5d).  
 
2.5. Triglyceride measurement and Nile Red staining 
 
For triglyceride measurement, fat body was homogenized in 100µl extraction 
buffer containing 200 mM potassium phosphate pH 4.8, 0.1 % Tween 20 (PBS/T) and 
immediately incubated for 5 min. at 70 ºC. One aliquot (20 µl) of the extract was 
mixed with 20 µl triglyceride reagent (Sigma) containing lipase activity. A second 
aliquot was mixed with the same amount of PBS/T for calculating the levels of free 
glycerol in the sample. Both tubes were incubated at 37 ºC for 30 min, and 
centrifuged at maximum velocity for 3 min at room temperature. One aliquot (30 µl) 
was incubated with 100 µl free glycerol reagent for 5 min at 37 ºC. Absorbance was 
read at 540 nm. Glycerol levels were determined using a standard curve submitted to 
the same conditions. Free glycerol calculated from the sample without lipase 
treatment was subtracted from the glycerol values in the treated samples. 
Triglycerides levels were estimated from the amount of glycerol obtained after lipase 
treatment. 
Fat body lipid droplets were visualized using Nile Red staining. Pieces of 
abdominal fat body were mounted in a medium containing 50% glycerol/PBS/T, Nile 
Red 1:55,000 (Molecular Probes). Tissues were analyzed using a Zeiss 
AxioImager.Z1 microscope (Carl Zeiss MicroImaging) for visualization of lipid 
droplets. 
 
2.6. Glycogen and protein measurements 
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Fat body was homogenized in 150 µl extraction buffer containing 200 mM 
sodium acetate pH 4.8. The homogenates were centrifuged at 10,000xg for 10 min at 
4 ºC. One aliquot (50 µl) of the supernatant was mixed with 1 unit α-
amyloglucosidase (Sigma). A second aliquot was mixed with the same amount of 
buffer for calculating the levels of free glucose in the sample. Both tubes were 
incubated at 40 ºC for 4h. Samples were then incubated with glucose oxidase reagent 
for 30 min at 37 ºC, followed by the addition of 100 µl of 12N H2SO4. The 
absorbance of each sample was read at 540 nm. Glucose content was quantified 
according to the manufacturer’s instructions (Glucose Assay (GO) Kit; Sigma). 
Glycogen content was determined using a glucose standard curve submitted to the 
same conditions. Free glucose calculated from the sample without α-
amyloglucosidase treatment was subtracted from the glycogen values. 
The protein content of samples was determined according to Bradford’s method, 
using bovine serum albumin as standard. 
 
2.7. Haemolymph collection and trehalose measurement 
 
Haemolymph samples (5µl) were collected in a microcapillary pipette, after 
cutting off the metathoracic legs, diluted in 5µl NaCl 0.4 M plus 4 % Protease 
Inhibitor (Sigma), fast frozen in liquid nitrogen and stored at -80ºC. Samples were 
centrifuged at 10,000xg for 10 min at 4 ºC and 200 µl 0.25 M Na2CO3 buffer were 
added to the supernatants. Samples were mixed by vortexing them for 1 min and 
incubated at 96 ºC for 2 h to inactivate all enzymes. Then, 120 µl of 1 M acetic acid 
and 480 µl 0.25 M Na-acetate (pH 5.2) were added, and the solution was centrifuged 
at 12,000 rpm, room temperature for 10 min. One aliquot (100 µl) of the supernatant 
was incubated overnight at 37 ºC with 2 µl porcine kidney trehalase (Sigma) in order 
to convert trehalose into glucose. A second aliquot was mixed with the same amount 
of buffer and incubated in the same way for calculating the levels of free glucose in 
the sample. The amount of glucose in 50 µl of the above solutions was calculated as 
in the case of glycogen measurement but using a trehalase-treated trehalose standard 
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curve. Trehalose concentration was determined after subtracting the amount of 
glucose without trehalase treatment. 
 
3. Results 
 
3.1. Cloning of Bmm, GlyP, AspAT, PC and PEPCK cDNAs 
 
Using degenerate primers and cDNA from diverse tissues, we attained fragments 
of differing lengths for the different studied genes . In the case of PEPCK, we 
employed 5’- and 3’-RACE methods to attain the full-length sequence. A BLAST 
database search indicated that the proteins were the B. germanica orthologs of 
Brummer lipase (BgBmm, GenBank accession number: HG005308), glycogen 
phosphorylase (BgGlyP, HG005309), aspartate aminotransferase (BgAspAT, 
HG005310), pyruvate carboxylase (BgPC, HG005311) and phosphoenolpyruvate 
carboxykinase (BgPEPCK, HG005312). 
 
3.2. BgFoxO knockdown prevents the starvation-induced activation of BgHTH 
expression 
 
mRNA levels of BgHTH were analyzed in the CC of fed and starved, 5 day old 
adult females. Results showed that BgHTH expression is upregulated in starved 
females (Fig. 1A).  
To study the effect of BgFoxO in the CC, its expression was depleted by RNAi. 
dsRNA targeting BgFoxO (dsFoxO) or a non-homologous dsRNA (dsMock) were 
administrated in the first day of ootheca transport. The ootheca was removed 12 days 
later and a second gonadotrophic cycle was triggered. A group of females were 
normally fed, whereas a second group was maintained without food and only water 
was provided. Dissections were performed the day of the ootheca removal and 5 days 
later. Results showed that dsFoxO treatment induced significant decreases of mRNA 
BgFoxO in the CC of all of the experimental conditions studied (0 d, 5 d fed and 5 d 
starved). In particular, in the starved females, dsFoxO treatment produced an 82% 
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significant reduction in BgFoxO mRNA levels. BgHTH mRNA levels were also 
studied under the experimental conditions. Results showed that, although starvation 
induced an increase of BgHTH mRNA levels the increase was not observed in 
starved dsFoxO females (Fig. 1A, C). 
 
3.3. Lipolysis is reduced and TAG are accumulated in BgFoxO-depleted females 
 
One of the enzymes involved in fat body lipolysis is Bmm. After proving the 
efficiency of dsFoxO treatment on the reduction of BgFoxO mRNA in fat body (Fig. 
2A), BgBmm mRNA levels were analyzed for the different experimental conditions. 
Results showed that BgFoxO knockdown produced a decrease in BgBmm levels in 0 
and 5 day old fed females (Fig. 2B). Results also indicated that starvation induced a 
2.3-fold significant increase in BgBmm mRNA in control females (p = 0.0022, 
Student’s t test), whereas dsFoxO treatment eliminated this starvation-induced 
increase in BgBmm mRNA levels (Fig. 2B). 
In parallel to BgBmm expression levels, TAG content in abdominal fat body was 
higher in dsFoxO-treated females (Fig. 2C, D). Even during starvation, when control 
(dsMock) females had exhausted the whole of their TAG stores, dsFoxO starved 
females maintained TAG levels that were more than 20-fold higher (Fig. 2C). 
 
3.3. Glycogenolysis is reduced in fat body but not in muscle in BgFoxO-depleted 
females 
 
Glycogen phosphorylase (GlyP) is the key enzyme in glycogenolysis. We 
measured BgGlyP mRNA and glycogen levels in fat body and muscle of females 
under the different experimental conditions. Fat body BgGlyP mRNA levels 
underwent a six-fold significant increase (p < 0.0001, Student’s t test) in starved 
females compared to fed females, but this increase was reduced in the case of 
dsFoxO-treated starved females (Fig. 3A). In parallel, fat body glycogen levels were 
lower in 0 and 5 day old, fed dsFoxO females compared to the controls. In the case of 
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starved females, the expected very low fat body glycogen levels observed in control 
animals was significantly increased in dsFoxO (Fig. 3B). 
In the case of muscle, after confirming that dsFoxO also triggered a reduction of 
BgFoxO mRNA in muscle tissue (Fig. 4A), we did not observe a reduction of 
BgGlyP mRNA in any of the cases, not even in starvation conditions (Fig. 4B). And, 
although we again found a reduction in glycogen levels in 0 and 5 day old fed 
females, we did not observe the increase in glycogen levels in the muscle of dsFoxO 
starved females which was observed in fat body for such case (Fig. 4C). 
 
3.4. BgFoxO knockdown reduces circulating trehalose levels and prevents the 
starvation-induced activation of BgPEPCK expression  
 
We also studied haemolymph trehalose concentration and mRNA levels of key 
enzymes involved in gluconeogenesis.Results showed that BgFoxO RNAi treatment 
produced a significant decrease in haemolymph trehalose in all the experimental 
conditions (Fig. 5).  
With respect to gluconeogenesis, we analyzed mRNA levels of different enzymes 
involved in the process. A 7-fold significant increase in phosphoenolpyruvate 
carboxykinase (BgPEPCK) mRNA levels was observed in control starved compared 
to fed females (p < 0.0001, Student’s t test). This increase was abolished by dsFoxO 
treatment (Fig. 6A). In addition, dsFoxO 5 day old fed females showed a significant 
reduction in fat body aspartate aminotransferase (BgAspAT) mRNA levels compared 
to controls. A relative (27%) increase in BgAspAT levels was observed in control 
starved compared to fed females; this increase being eliminated in dsFoxO starved 
females, although the difference compared to controls was not significant (Fig. 6B). 
We didn’t find any differences in pyruvate carboxylase (BgPC) mRNA levels 
between 5 day old control and dsFoxO, neither in the fed nor in the starved groups 
(Fig. 6C). 
Muscle protein levels, estimated from the calculation of total protein in the legs, 
were constant across all the experimental conditions, except in the case of dsFoxO 
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starved females where a significant decrease, ca. 44%, in total protein was observed 
(Fig. 6D). 
 
4. Discussion 
 
Energy homeostasis implies close regulation of the accumulation and 
mobilization of energy reserves. In different animal models, which include insects 
and mammals, these reserves are mainly glycogen and TAG [26, 33]. It has been 
described for insects that the control of energy expenditure is produced through two 
different systems. The first one starts with the binding of the neuropeptide AKH/HTH 
to its receptor and the subsequent activation of PKA which, in turn, induces 
glycogenolysis by activating GlyP at a post-translational level [14, 26]. The second 
system involves the stimulation of lipolysis through the activation of the expression 
of the lipase Bmm, mediated by the transcription factor FoxO [26, 28-29]. 
FoxO is the major coordinator of the transcriptional response to nutrients in D. 
melanogaster, C. elegans or mammals [20, 23, 34]. In the fruit fly, in fact, it has been 
estimated that 28% of the nutrient responsive genes are transcriptionally regulated by 
activated dFoxO [35]. Therefore, the study of the transcriptional changes that occur in 
a situation of FoxO knockdown are of great importance when studying metabolism in 
nutrient deprivation conditions. 
In B. germanica, starvation induced the increase of HTH mRNA levels in the CC 
(Fig. 1A, C). An increase in HTH mRNA levels has also been reported in starved 
adult females of the cockroach Blaberus discoidalis [36]. The HTH mRNA increase 
observed in starved B. germanica was eliminated in BgFoxO knocked down 
(dsFoxO) females (Fig. 1B, C), which indicates that FoxO is required for the 
activation of HTH expression during starvation.  
The fat body, the insect analog to vertebrate liver and adipose tissue, is the main 
energy reserve organ in insects. This energy is mainly stored in the form of glycogen 
and triacylglycerides (TAG). In B. germanica, although starvation induces an 
increase in fat body BgBmm mRNA levels, dsFoxO treatment reduces BgBmm 
mRNA and, concomitantly, increases TAG levels in both fed and starved females 
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(Fig. 2B-D). These results again indicate that BgFoxO activates BgBmm expression. 
As stated above, D. melanogaster Bmm is regulated through direct binding of dFoxO 
to its promoter [29], and in the tsetse fly, Glossina morsitans, FoxO knockdown also 
produces a decrease in Bmm mRNA levels [37]. 
In the mosquito Culex pipiens, short day lenghts induce entering into diapause, 
characterized, among other features, by the sequestration of lipid reserves, whereas 
FoxO knockdown reduces lipid stores in diapausing females [38]. On the other hand, 
high abundance of FoxO protein has been detected in the fat body of C. pipiens 
females in early diapause, and these high levels of FoxO disappeared in response to 
juvenile hormone treatment [39]. These results point to a specific endocrine 
regulation and a different effect of FoxO in the animals that have an adult 
reproductive diapause. 
GlyP is the enzyme responsible of glycogen mobilization. Its enzymatic activity 
degrades glycogen and produces glucose-1-phosphate, which is eventually 
transformed into trehalose or enters glycolysis. Present results demonstrate that in the 
fat body of B. germanica females, BgGlyP is activated in starvation conditions and 
that this activation is reduced in BgFoxO knockdown individuals (Fig. 3A), 
suggesting that BgFoxO is required for the activation of fat body GlyP expression. In 
parallel with BgGlyP mRNA reduction, a significant increase in fat body glycogen 
levels was observed in dsFoxO females (Fig. 3B), indicating that the degradation of 
glycogen is partially impaired in these animals. In contrast, a decrease in fat body 
glycogen levels was observed in dsFoxO fed animals (Fig. 3B). Provided that, in this 
case, no changes were observed in BgGlyP, a possible explanation would imply an 
effect of BgFoxO knockdown on glycogenesis. 
In contrast to the results observed in fat body, no changes were shown in muscle 
BgGlyP mRNA levels due to dsFoxO treatment (Fig. 4B). Furthermore, no 
differences in glycogen content were observed between control and dsFoxO starved 
females (Fig. 4C). Nevertheless, as it occurred in fat body, a reduction in glycogen 
levels between control and dsFoxO was attained in fed females (Fig. 4C), which 
again points to an effect of BgFoxO knockdown on glycogenesis. 
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It has already been reported that AKH/HTH stimulates GlyP activity in the fat 
body via phosphorylation of the protein that converts the b form, which is active only 
in the presence of AMP, to the a form, which is active by itself [11]. Here, we have 
demonstrated that, besides this post-translational regulatory system, FoxO is required 
for activating GlyP expression in fat body of starved females. In the case of the 
muscle, we haven’t found differences in BgGlyP mRNA which indicates that 
BgFoxO does not have the same effect in this tissue. In addition, extremely low 
AKH/HTH receptor levels have been reported in muscle compared to fat body in all 
the insects for which this has been studied [40-42]. All these results explain why we 
haven’t found significant differences in muscle glycogen content between control and 
dsFoxO starved females. 
Trehalose concentration in the haemolymph was lower in dsFoxO females for all 
the different experimental conditions (Fig. 5). A possible explanation of these lower 
trehalose levels would involve a higher level of trehalose entering into the fat body in 
dsFoxO animals for lipid synthesis. Higher levels of TAG in dsFoxO females (Fig. 
2C) would point in this direction, although specific experiments should be performed 
to determine the trehalose uptake and lipogenesis rates. 
Under starvation, glucose is made from glycerol, lactate and amino acids formed 
by proteolysis of muscle proteins [43]. In our case and with respect to the fat body 
enzymes related to gluconeogenesis, starvation induced a significant increase in 
BgPEPCK levels in control females, but this increase was abolished in the case of 
dsFoxO (Fig. 6A), which again indicates that BgFoxO induces BgPEPCK expression 
during starvation. Changes indicating the same conclusion were found in the case of 
BgAspAT, although the differences were not significant (Fig. 6B). Similar results 
showing FoxO-dependent activation of PEPCK expression have been reported in D. 
melanogaster [29, 44] and in mammals [24, 44]. And with respect to the regulatory 
effect of FoxO on AspAT expression, in C. elegans the presence of canonical binding 
sites for DAF-16 (the C. elegans FoxO homolog) in the promoter of AspAT has been 
demonstrated, and the specificity of DAF-16 binding was confirmed by chromatin 
immunoprecipitation (ChIP) [45].  
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The decrease in gluconeogenetic enzymes found in dsFoxO starved females will 
impair the use of gluconeogenic substrates for the production of glucose. One of these 
substrates may be glucogenic amino acids coming from the muscle. In our 
experiments a decrease in muscle protein was observed in the case of starved dsFoxO 
females (Fig. 6D). A possible explanation for these low protein levels is the low 
levels of glucose synthesis in the fat body, caused by the impaired gluconeogenesis in 
dsFoxO starved females, which would signal to the muscle to increase proteolysis. 
In summary, our results indicate that FoxO induces the expression of genes 
related to catabolism in a situation of nutrient shortage in a basal insect, as is B. 
germanica. Of special relevance is the activation of the expression of the endocrine 
peptide HTH and the enzyme GlyP; because it connects the action of FoxO to an 
already known mechanism (the effect of HTH on GlyP protein activation) and 
because our result is analogous to the reported activity of FoxO in the activation of 
the transcription of mammalian hypothalamic peptides (Agouti-related peptide and 
neuropeptide Y) related to energy expenditure and which are important in different 
metabolic disorders [46]. 
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FIGURE LEGENDS 
 
Fig. 1. Hypertrehalosemic hormone (BgHTH) expression and effect of BgFoxO 
RNAi treatment on corpora cardiaca (CC) from Blattella germanica females. (A) 
BgHTH mRNA levels in CC from fed and starved 5 day-old adult females (n=5). (B 
and C) Effect of BgFoxO RNAi. dsRNA targeting BgFoxO (dsFoxO) or a non-
homologous dsRNA (dsMock) were administrated in the first day of ootheca 
transport. The ootheca was removed 12 days later and a second gonadotrophic cycle 
was triggered. A group of females were normally fed, whereas a second group was 
maintained without food and only water was provided. Dissections were performed 
the day of the ootheca removal (0d) and 5 days later (5d Fed and 5d Starved). (B) 
BgFoxO mRNA levels (n=3-7). (C) BgHTH mRNA levels (n=3-7). Y-axis indicates 
copies per copy of BgActin 5C. Results are expressed as the mean ± S.E. Asterisks 
represent significant differences between dsMock and dsFoxO (Student’s t test, 
*P<0.05; **P<0.01; ***P<0.005). 
 
Fig. 2. Effect of BgFoxO RNAi treatment on fat body from Blattella germanica 
females. Experimental procedure was the same as in Fig. 1. (A) BgFoxO mRNA 
levels (n=6-16). (B) Brummer lipase (BgBmm) mRNA levels (n=5-7). (C) 
Triacylglycerides (TAG) levels (n=5-6). (D) Representative images of fat bodies from 
dsMock and dsFoxO 5d fed females stained with Nile Red. Scale bars: 50 µm. (A) 
and (B) Y-axis indicate copies per copy of BgActin 5C. Results are expressed as the 
mean ± S.E. Asterisks represent significant differences between dsMock and dsFoxO 
(Student’s t test, *P<0.05; **P<0.005; P<0.0001). 
 
Fig. 3. Effect of BgFoxO RNAi treatment on fat body from Blattella germanica 
females. Experimental procedure was the same as in Fig. 1. (A) Glycogen 
phosphorylase (BgGlyP) mRNA levels (n=7-9). (B) Glycogen levels (n=5-6). (A) Y-
axis indicates copies per copy of BgActin 5C. Results are expressed as the mean ± 
S.E. Asterisks represent significant differences between dsMock and dsFoxO 
(Student’s t test, *P<0.05; **P<0.005; P<0.0001). 
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Fig. 4. Effect of BgFoxO RNAi treatment on leg muscle from Blattella germanica 
females. Experimental procedure was the same as in Fig.1. (A) BgFoxO mRNA 
levels (n=6-11). (B) Glycogen phosphorylase (BgGlyP) mRNA levels (n=5-10). (C) 
Glycogen levels (n=4-6). (A) and (B) Y-axis indicate copies per copy of BgActin 5C. 
Results are expressed as the mean ± S.E. Asterisks represent significant differences 
between dsMock and dsFoxO (Student’s t test, *P<0.05; **P<0.0005; P<0.0001). 
 
Fig. 5. Effect of BgFoxO RNAi treatment on haemolymph trehalose levels of 
Blattella germanica females. Experimental procedure was the same as in Fig. 1. 
Results are expressed as the mean ± S.E, (n=5-10). Asterisks represent significant 
differences between dsMock and dsFoxO (Student’s t test, *P<0.05). 
 
Fig. 6. Effect of BgFoxO RNAi treatment on fat body and leg muscle from Blattella 
germanica females. Experimental procedure was the same as in Fig. 1. (A) Fat body 
phosphoenolpyruvate carboxylase (BgPEPCK) mRNA levels (n=6-9). (B) Fat body 
aspartate aminotransferase (BgAspAT) mRNA levels (n=5-10). (C) Fat body 
pyruvate carboxylase (BgPC) mRNA levels (n=5-10). (D) Leg protein levels (n=5-6). 
(A), (B) and (C) Y-axis indicate copies per copy of BgActin 5C. Results are 
expressed as the mean ± S.E. Asterisks represent significant differences between 
dsMock and dsFoxO (Student’s t test, *P<0.05; **P<0.001). 
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Table 1. Primer sequences. 
 
Primers used for cloning 
 
 
 
Primers used for qPCR 
 
BgBmm F1 TTYGCNGGNTGYGGNTT 
BgBmm F2 TAYGAYGGNAARAAYGTNAT 
BgBmm R1 GTNACRTCRAADATYTCNGT 
BgBmm R2 GCRTCRTCRAANCCYTG 
BgGlyP F1 AARTTYCARAAYAARACNAAYGG 
BgGlyP F2 ATGATHGGNGGNAARGCNGC 
BgGlyP R1 CATYTCNACRTTNGCNCCRTC 
BgAspAT F1 TGYGCNCAYAAYCCNACNGG 
BgAspAT F2 TTYGAYWSNGCNTAYCARGG 
BgAspAT F3 TTTGGTGCAGGTGATGTTGCAAGA 
BgAspAT R1 TANSWRAACATNCCDATYTG 
BgPC F1 CAYGARTGYCCNTGGGARMG 
BgPC F2 CCNAAYATHCCNTTYCARATG 
BgPC R1 TTYTGNACCATRAAYTGNGC 
BgPC R2 TTYTTNACRTCYTCRAARAA 
BgPEPCK F1 GGNTGGYTNGCNGARCAYATG 
BgPEPCK R1 GGNCKCATNGCRAANGGRTC 
BgPEPCK R2 TCRAAYTTCATCCANGCDATRTC 
BgHTH qPCR Fwd AGACCTTGGTAGTTGTGGTGGC 
BgHTH qPCR Rv GGATTCCTGATCTCTTGCCTGT 
BgBmm qPCR Fwd GACATCTGTCCCCGTGATTTG 
BgBmm qPCR Rv CCTGTAGATATTGTGGCGAGACAA 
BgGlyP qPCR Fwd TCATGCCTGCGACAGATCTC 
BgGlyP qPCR Rv CTCCATTCAACTGGAACTTCATGT 
BgAspAT qPCR Fwd CAAGGATGATGCTCAAAGAACG 
BgAspAT qPCR Rv AACAATGCGAGCTCCATGG 
BgPC qPCR Fwd CGTTGCATCTCTTCAAGGCA 
BgPC qPCR Rv TGTGCGTGTTTGTTCCCAAT 
BgPEPCK qPCR Fwd ATCTTGCCATGATGTGCCCT 
BgPEPCK qPCR Rv TTATTTGATGTGCCTGGTGCA 
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